Sézary cell counts in erythrodermic cutaneous T-cell lymphoma: Implications for prognosis and staging

Leukemia and Lymphoma

Volumn 47, Issue 9, 2006, Pages 1841-1856

  Vonderheid, Eric C ^a   Pena, Jane ^b   Nowell, Peter ^c  

^a DEPARTMENT OF PATHOLOGY   (United States)

^b TEMPLE UNIVERSITY HOSPITAL   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Cutaneous T cell lymphoma; Erythroderma; Prognosis; S zary syndrome; Staging

Indexed keywords

CHLORAMBUCIL; CYCLOPHOSPHAMIDE; LACTATE DEHYDROGENASE; METHOTREXATE; PREDNISONE; VINCRISTINE;

ADULT; AGED; AGING; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER STAGING; CD4 CD8 RATIO; CELL COUNT; CHROMOSOME ANALYSIS; CONTROLLED STUDY; CUTANEOUS T CELL LYMPHOMA; DRUG EXPOSURE; ERYTHRODERMA; FEMALE; HUMAN; LACTATE DEHYDROGENASE BLOOD LEVEL; LYMPH NODE METASTASIS; LYMPHADENOPATHY; MAJOR CLINICAL STUDY; MALE; MOLECULAR CLONING; PRIORITY JOURNAL; PROGNOSIS; QUANTITATIVE ANALYSIS; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SEZARY CELL;

ADULT; AGED; AGED, 80 AND OVER; CELL COUNT; DERMATITIS, EXFOLIATIVE; FEMALE; HUMANS; LYMPH NODES; LYMPHOMA, T-CELL, CUTANEOUS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; RETROSPECTIVE STUDIES; SEZARY SYNDROME; SKIN NEOPLASMS;

EID: 33750450142     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.1080/10428190600709655     Document Type: Article

References (67)

1. Vonderheid, E and Bernengo, M and Burg, G and Duvic, M and Heald, P and Laroche, L and (2002) Update on erythrodermic cutaneous T-cell lymphoma: report of the International Society for Cutaneous Lymphomas J Am Acad Dermatol, 46, pp. 95-106.
2. Vonderheid, E and Bernengo, M. (2003) The Sézary syndrome: hematologic criteria Hematol Oncol Clin N Am, 17, pp. 1367-1389.
3. Willemze, R and Jaffe, E and Burg, G and Cerroni, L and Berti, E and Swerdlow, S and (2005) WHO-EORTC classification for cutaneous lymphomas Blood, 105, pp. 3768-3785.
4. Sévzary, A and Bouvrain, Y. (1938) Erythrodermie avec présence de cellules monstrueuses dans le derme et le sang circulant Bull Soc Fr Derm Syph, 45, pp. 254-260.
5. Lutzner, M and Jordan, H. (1968) The ultrastructure of an abnormal cell in Sézary's syndrome Blood, 31, pp. 719-726.
6. Lutzner, M and Hobbs, J and Horvath, P. (1971) Ultrastructure of abnormal cells in Sézary syndrome, mycosis fungoides, and parapsoriasis en plaque Arch Dermatol, 103, pp. 375-386.
7. Flandrin, G and Brouet, J. (1974) The Sézary cell: Cytologic, cytochemical, and immunologic studies Mayo Clin Proc, 49, pp. 575-583.
8. Meyer, C and van Leeuwen, A and van der Loo, E and van de Putte, L and van Vloten, W. (1977) Cerebriform (Sézary like) mononuclear cells in healthy individuals: A morphologically distinct population of T cells Virchows Arch B Cell Pathol, 25, pp. 95-104.
9. Weinberg, J and Jaworsky, C and Benoit, B and Telegan, B and Rook, A and Lessin, S. (1995) The clonal nature of circulating Sézary cells Blood, 86, pp. 4257-4262.
10. Preesman, A and Schrooyen, S and Toonstra, J and van der Putte, S and Rademakers, L and Willemze, R and (1995) The diagnostic value of morphometry on blood lymphocytes in erythrodermic actinic reticuloid Arch Dermatol, 131, pp. 1298-1303.
11. Litovitz, T and Lutzner, M. (1974) Quantitative measurements of blood lymphocytes from patients with chronic lymphocytic leukemia and the Sézary syndrome J Natl Cancer Inst, 53, pp. 75-77.
12. Reinhold, U and Herpertz, M and Kukel, S and Oltermann, I and Uerlich, M and Kreysel, H. (1994) Induction of nuclear contour irregularity during T-cell activation via the T-cell receptor/CD3 complex and CD2 antigens in the presence of phorbol esters Blood, 83, pp. 703-706.
13. Winkelmann, R and Linman, J. (1973) Erythroderma with atypical lymphocytes (Sézary syndrome) Am J Med, 55, pp. 192-198.
14. Winkelmann, R. (1974) Clinical studies of T-cell erythroderma in the Sézary syndrome Mayo Clin Proc, 49, pp. 519-525.
15. Winkelmann, R and Hoagland, H. (1980) The Sézary cell in the blood of patients with mycosis fungoides Dermatologica, 160, pp. 73-79.
16. Winkelmann, R and Peters, M. (1981) Absolute number of circulating Sézary cells [letter] Arch Dermatol, 117, pp. 382.
17. Winkelmann, R and Buechner, S and Diaz-Perez, J. (1984) Pre-Sézary syndrome J Am Acad Dermatol, 10, pp. 992-999.
18. Buechner, S and Winkelmann, R. (1983) Pre-Sézary erythroderma evolving to Sezary syndrome. A report of seven cases Arch Dermatol, 119, pp. 285-291.
19. Lutzner, M and Edelson, R and Schein, P and Green, I and Kirkpatrick, C and Ahmed, A. (1975) Cutaneous T-cell lymphomas: The Sézary syndrome, mycosis fungoides, and related disorders Ann Intern Med, 83, pp. 534-552.
20. Willemze, R and van Vloten, W and Hermans, J and Damsteeg, M and Meijer, C. (1983) Diagnostic criteria in Sézary's syndrome: A multiparameter study of peripheral blood lymphocytes in 32 patients with erythroderma J Invest Dermatol, 81, pp. 392-397.
21. Vonderheid, E and Sobel, E and Nowell, P and Finan, J and Helfrich, M and Whipple, D. (1985) Diagnostic and prognostic significance of Sézary cells in peripheral blood smears from patients with cutaneous T cell lymphoma Blood, 66, pp. 358-366.
22. Schechter, G and Sausville, E and Fischmann, A and Soehnlen, F and Eddy, J and Matthews, M and (1987) Evaluation of circulating malignant cells provides prognostic information in cutaneous T cell lymphoma Blood, 69, pp. 841-849.
23. Toonstra, J and van Weelden, H and Gmelig Meyling, F and van der Putte, S and Schiere, S and Baart de la Faille, H. (1985) Actinic reticuloid simulating Sézary syndrome. Report of two cases Arch Dermatol Res, 277, pp. 159-166.
24. D'Incan, M and Souteyrand, P and Bignon, Y and Fonck, Y and Roger, H. (1992) Hydantoin-induced cutaneous pseudolymphoma with clinical, pathologic, and immunologic aspects of Sézary syndrome Arch Dermatol, 128, pp. 1371-1374.
25. Sausville, E and Eddy, J and Makuch, R and Fischmann, A and Schechter, G and Matthews, M and (1988) Histopathologic staging at initial diagnosis of mycosis fungoides and the Sézary syndrome: Definition of three distinctive prognostic groups Ann Intern Med, 109, pp. 372-382.
26. Toro, J and Stoll, H, Jr and Stomper, P and Oseroff, A. (1997) Prognostic factors and evaluation of mycosis fungoides and Sézary syndrome J Am Acad Dermatol, 37, pp. 58-67.
27. Bernengo, M and Quaglino, P and Novelli, M and Cappello, N and Doveil, G and Lisa, F and (1998) Prognostic factors in Sezary syndrome: A multivariate analysis of clinical, haematological and immunological features Ann Oncol, 9, pp. 857-863.
28. Wang, S and Li, N and Heald, P and Fisk, J and Fadare, O and Howe, J and (2004) Flow cytometric DNA ploidy analysis of peripheral blood from patients with sezary syndrome: Detection of aneuploid neoplastic T cells in the blood is associated with large cell transformation in tissue Am J Clin Pathol, 122, pp. 774-782.
29. Scarisbrick, J and Whittaker, S and Evans, A and Fraser-Andrews, E and Child, F and Dean, A and (2001) Prognostic significance of tumor burden in the blood of patients with erythrodermic primary cutaneous T-cell lymphoma Blood, 97, pp. 624-630.
30. Wasik, M and Vonderheid, E and Bigler, R and Marti, R and Lessin, S and Polansky, M and (1996) Increased serum concentration of the soluble interleukin-2 receptor in cutaneous T-cell lymphoma. Clinical and prognostic implications. Arch Dermatol 1996; pp. 42-47.
31. Diamandidou, E and Colome, M and Fayad, L and Duvic, M and Kurzrock, R. (1999) Prognostic factor analysis in mycosis fungoides/Sézary syndrome J Am Acad Dermatol, 40, pp. 914-924.
32. Foulc, P and N'Guyen, J and Dreno, B. (2003) Prognostic factors in Sézary syndrome: A study of 28 patients Br J Dermatol, 149, pp. 1152-1158.
33. Tancrede-Bohin, E and Ionescu, M and de La Salmoniere, P and Dupuy, A and Rivet, J and Rybojad, M and (2004) Prognostic value of blood eosinophilia in primary cutaneous T-cell lymphomas Arch Dermatol, 140, pp. 1057-1061.
34. Nowell, P and Finan, J and Vonderheid, E. (1982) Clonal characteristics of cutaneous T cell lymphomas: Cytogenetic evidence from blood, lymph nodes, and skin J Invest Dermatol, 78, pp. 69-75.
35. Bunn, P, Jr and Lamberg, S. (1979) Report of the committee on staging and classification of cutaneous T-cell lymphomas Cancer Treat Rep, 63, pp. 725-728.
36. Kim, Y and Bishop, K and Varghese, A and Hoppe, R. (1995) Prognostic factors in erythrodermic mycosis fungoides and the Sézary syndrome Arch Dermatol, 131, pp. 1003-1008.
37. Marti, R and Pujol, R and Servitje, O and Palou, J and Romagosa, V and Bordes, R and (2003) Sézary syndrome and related variants of classic cutaneous T-cell lymphoma. A descriptive and prognostic clinicopathologic study of 29 cases Leuk Lymphoma, 44, pp. 59-69.
38. Jacyk, W and Ungerer, J. (1991) Serum lactate dehydrogenase activity in exfoliative dermatitis J Dermatol, 18, pp. 743.
39. Sausville, E and Worsham, G and Matthews, M and Makuch, R and Fischmann, A and Schechter, G and (1985) Histologic assessment of lymph nodes in mycosis fungoides/Sézary syndrome (cutaneous T-cell lymphoma): clinical correlations and prognostic import of a new classification system Hum Pathol, 16, pp. 1098-1109.
40. Lutzner, M and Emerit, I and Durepaire, R and Flandrin, G and Grupper, C and Prunieras, M. (1973) Cytogenetic, cytophotometric, and ultrastructural study of large cerebriform cells of the Sézary syndrome and description of the small-cell variant J Natl Cancer Inst, 50, pp. 1145-1162.
41. Heald, P and Yan, S and Edelson, R. (1994) Profound deficiency in normal circulating T cells in erythrodermic cutaneous T-cell lymphoma Arch Dermatol, 130, pp. 198-203.
42. Vonderheid, E and Boselli, C and Conroy, M and Casaus, L and Espinoza, L and Venkataramani, P and (2005) Evidence for restricted Vbeta usage in the leukemic phase of cutaneous T cell lymphoma J Invest Dermatol, 124, pp. 651-661.
43. Kuchnio, M and Sausville, E and Jaffe, E and Greiner, T and Foss, F and McClanahan, J and (1994) Flow cytometric detection of neoplastic T cells in patients with mycosis fungoides based on levels of T-cell receptor expression Am J Clin Pathol, 102, pp. 856-560.
44. Edelman, J and Meyerson, H. (2000) Diminished CD3 expression is useful for detecting and enumerating Sézary cells Am J Clin Pathol, 114, pp. 467-477.
45. Washington, L and Huh, Y and Powers, L and Duvic, M and Jones, D. (2002) A stable aberrant immunophenotype characterizes nearly all cases of cutaneous T-cell lymphoma in blood and can be used to monitor response to therapy BMC Clin Pathol, 2, pp. 5-12.
46. Bogen, S and Pelley, D and Charif, M and McCusker, M and Koh, H and Foss, F and (1996) Immunophenotypic identification of Sézary cells in peripheral blood Am J Clin Pathol, 106, pp. 739-748.
47. Harmon, C and Witzig, T and Katzmann, J and Pittelkow, M. (1996) Detection of circulating T cells with CD4+ CD7 - Immunophenotype in patients with benign and malignant lymPphoproliferative dermatoses J Am Acad Dermatol, 35, pp. 404-410.
48. Bernengo, M and Novelli, M and Quaglino, P and Lisa, F and De Matteis, A and Savoia, P and (2001) The relevance of the CD4+ CD26 - Subset in the identification of circulating Sézary cells Br J Dermatol, 144, pp. 125-135.
49. Jones, D and Dang, N and Duvic, M and Washington, L and Huh, Y. (2001) Absence of CD26 expression is a useful marker for diagnosis of T-cell lymphoma in peripheral blood Am J Clin Pathol, 115, pp. 885-892.
50. Lima, M and Almeida, J and dos Anjos Teixeira, M and Queiros, M and Santos, A and Fonseca, S and (2003) Utility of flow cytometry immunophenotyping and DNA ploidy studies for diagnosis and characterization of blood involvement in CD4+ Sezary's syndrome Haematologica, 88, pp. 874-887.
51. Poszepczynska-Guigne, E and Schiavon, V and D'Incan, M and Echchakir, H and Musette, P and Ortonne, N and (2004) CD158k/KIR3DL2 is a new phenotypic marker of Sézary cells: Relevance for the diagnosis and follow-up of Sézary syndrome J Invest Dermatol, 122, pp. 820-823.
52. Burke, J and Colby, T. (1981) Dermatopathic lymphadenopathy. Comparison of cases associated and unassociated with mycosis fungoides Am J Surg Pathol, 5, pp. 343-352.
53. Vonderheid, E and Diamond, L and van Vloten, W and Scheffer, E and Meijer, C and Cashell, A and (1994) Lymph node classification systems in cutaneous T-cell lymphoma. Evidence for the utility of the Working Formulation of Non-Hodgkin's Lymphomas for Clinical Usage Cancer, 73, pp. 207-218.
54. Bakels, V and Van Oostveen, J and Geerts, M and Gordijn, R and Walboomers, J and Scheffer, E and (1993) Diagnostic and prognostic significance of clonal T-cell receptor beta gene rearrangements in lymph nodes of patients with mycosis fungoides J Pathol, 170, pp. 249-255.
55. Kern, D and Kidd, P and Moe, R and Hanke, D and Olerud, J. (1998) Analysis of T-cell receptor gene rearrangement in lymph nodes of patients with mycosis fungoides. Prognostic implications Arch Dermatol, 134, pp. 158-164.
56. Breneman, D and Raju, U and Breneman, J and Steele, P and McFadden, D and Cualing, H and (2003) Lymph node grading for staging of mycosis fungoides may benefit from examination of multiple excised lymph nodes J Am Acad Dermatol, 48, pp. 702-706.
57. Galindo, L and Garcia, F and Hanau, C and Lessin, S and Jhala, N and Bigler, R and (2000) Fine-needle aspiration biopsy in the evaluation of lymphadenopathy associated with cutaneous T-cell lymphoma (mycosis fungoides/Sézary syndrome) Am J Clin Pathol, 113, pp. 865-871.
58. Sigurdsson, V and Toonstra, J and Hezemans-Boer, M and van Vloten, W. (1996) Erythroderma. A clinical and follow-up study of 102 patients, with special emphasis on survival J Am Acad Dermatol, 35, pp. 53-57.
59. Axelrod, P and Lorber, B and Vonderheid, E. (1992) Infections complicating mycosis fungoides and Sezary syndrome JAMA, 267, pp. 1354-1358.
60. Kantor, A and Curtis, R and Vonderheid, E and van Scott, E and Fraumeni, J, Jr. (1989) Risk of second malignancy after cutaneous T-cell lymphoma Cancer, 63, pp. 1612-1615.
61. Scarisbrick, J and Child, F and Evans, A and Fraser-Andrews, E and Spittle, M and Russell-Jones, R. (1999) Secondary malignant neoplasms in 71 patients with Sézary syndrome Arch Dermatol, 135, pp. 1381-1385.
62. Green, S and Byar, D and Lamberg, S. (1981) Prognostic variables in mycosis fungoides Cancer, 47, pp. 2671-2677.
63. Shipp, M. (1994) Prognostic factors in aggressive non-Hodgkin's lymphoma: Who has 'high-risk' disease? Blood, 83, pp. 1165-1173.
64. Bernengo, M and Fierro, M and Novelli, M and Lisa, F and Appino, A. (1993) Soluble interleukin-2 receptor in Sézary syndrome: Its origin and clinical application Br J Dermatol, 128, pp. 124-129.
65. Kari, L and Loboda, A and Nebozhyn, M and Rook, A and Vonderheid, E and Nichols, C and (2003) Classification and prediction of survival in patients with the leukemic phase of cutaneous T cell lymphoma J Exp Med, 197, pp. 1477-1488.
66. Klemke, C and Mansmann, U and Poenitz, N and Dippel, E and Goerdt, S. (2005) Prognostic factors and prediction of prognosis by the CTCL Severity Index in mycosis fungoides and Sézary syndrome Br J Dermatol, 153, pp. 118-124.
67. Fraser-Andrews, E and Russell-Jones, R. (2001) Woolford AJ, Wolstencroft RA, Dean AJ, Whittaker SJ. Diagnostic and prognostic importance of T-cell receptor gene analysis in patients with Sézary syndrome Cancer, 92, pp. 1745-1752.